Earlier this week, the EU drugs regulator said a possible link between the AstraZeneca vaccine and a rare type of blood clot is possible, identifying at least 62 cases of the condition. The European Medicines Agency said its safety committee will probably issue an updated recommendation next week.

It was already noted that the U.K. has one of the world’s fastest-moving vaccine programs, administering shots to more than half of all adults by late March. New daily Covid cases and deaths have fallen to the lowest levels since September, even as infections surge again across much of the European Union, where immunizations have lagged.

The Netherlands became the latest country to prohibit the use of the vaccine after 25 new cases of rare blood clots that were perhaps connected to AstraZeneca Plc’s Covid-19 vaccine was revealed. As of March 24, there are an additional 30 reported cases. The Medicines and Healthcare Products Regulatory Agency said in a statement Thursday that the benefits of the shot continue to outweigh the risks.

The Netherlands took a temporary move to suspend the use of the vaccine for people under 60 years old. AstraZeneca is now facing questions over trial results and delivery schedules as the number of blood-clot cases and the number of countries to suspend the use continue to rise.

David Werring, professor of clinical neurology at University College London’s Institute of Neurology said in an interview that “the key thing to remember is how rare these brain clots are, and how powerful the proven benefit of vaccination is against Covid,”. On top of that, the UK continues to forge ahead in its program. According to MHRA that 30 incidents were out of 18.1 million doses of AstraZeneca vaccine is given by March 24. Prior to that, the agency disclosed five cases on March 18, out of 11 million shots.

On the other hand, there were no reports of the same reactions to the vaccine from Pfizer Inc. and BioNTech SE, which is also being used in Britain.

The AstraZeneca and Pfizer vaccines have shown “very high levels of protection” against Covid-19, according to MHRA, adding that “all vaccines and medicines have some side effects.”

RECENT POST

Sputnik-V rollout in Delhi, Postponed Once Again!


Treatment Using Genetic Engineering and Light-Activated Therapy has Helped a Blind Man Regain Partial Sight in One Eye


Sanofi S.A. has Agreed to a Pensions Package of Approximately £770 million ($1.1 billion)


French CDMO Yposkesi to Build a Second Commercial Cell and Gene Therapy Plant


Unusable Vaccine Doses at Baltimore Plant Investigated by FDA


Danish government needs to reevaluate dropped antibodies


WHO currently utilizing Greek letters in order for Covid variation names


GP Clinics is now ready to accept COVID-19 Vaccinations for ages over 50


EU Signed a Contract with Pfizer for Almost 1.8 Billion Doses of the Coronavirus Vaccine


Pfizer has gauge $26 billion in Covid-19 antibody deals this year


Hospira, Inc Under Investigation After Reported Mislabeling


Global Access to COVID-19 Vaccines


Moderna Is Testing a New Version of Its COVID-19 Vaccine That Wouldn’t Require Ultra-Cold Storage


No Logical Proof COVID-19 Vaccine Affects Menstruation or Fertility


Full Steam Ahead on Johnson & Johnson and AstraZeneca Vaccines


India Established a Record for Daily Infections Worldwide


Vaccines to Detainees at Guantanamo Bay are now being Offered by the U.S.


Israel's Quick and Effective Vaccine Rollout


J&J Pause a Mere Bump in the U.S. Antibody Rollout?


Stoppage in the Utilization of Johnson and Johnson's Covid-19 Vaccine


Supply Constraints Ease in U.S. Vaccine Rollout


Israel's Vaccine Rollout Curbs Covid-19 Spread


Effects of England's salt reduction Program


The COVID-19 Vaccination Race in Asia


UK and the EU are as yet entangled in an unpleasant disagreement about a deficiency of antibodies across Europe


Progress of COVAX Deliveries


Non-AstraZeneca option for under 30s; E.U. tracks down a 'potential connect' to rare clots


Emergent BioSolutions Threw Out Millions of Doses of Covid-19 Vaccines


Kidney Transplants on the Rise


Vaccine Passports


Coronavirus Briefing: U.S. Economy Bounces Back


India Recorded its Highest Tally of New Coronavirus Infections


Moderna dishes out for CEO security as its COVID-19 immunization gets the spotlight


How soon until the Pfizer antibody is ready for aged 12-15 years old?


Antibody injections could turn out to be more reasonable with the new production method


NHS study finds that CT scan gets 70% of Lung Cancer at the Beginning Phase


How to Apply DQ/IQ/OQ/PQ in New Framework


Design of an Efficient Stability Programme -Bracketing and Matrixing


QP Declaration


Negotiations on Cost and Availability of New Pharmaceuticals


Covid-19 in China - Statistics & Facts


5 Health Care Stocks to Bet on as Coronavirus Woes Linger


Coronavirus Impact on the Tourism Industry Worldwide


Cold chain distribution; route qualification approaches


The v model in validation


GAMP V computer system validation